Skip to main content
. 2019 Nov 15;11(11):1021–1030. doi: 10.4251/wjgo.v11.i11.1021

Figure 2.

Figure 2

Kaplan-Meier curves of progression-free survival and overall survival according to 5-fluorouracil exposure in each treatment group. A, B: progression-free survival in capecitabine group and S-1 group according to 5-fluorouracil exposure; C, D: overall survival analysis in capecitabine group and S-1 group according to 5-fluorouracil exposure.